비치료용 바이오 분자 시장 보고서(2026년)

Non-therapeutic biomolecules refer to organic compounds produced by cells and living organisms. These compounds vary in shape and size and perform a wide range of functions within the body.

The main types of traditional pharmaceutical non-therapeutic biomolecules include enzymes, recombinant proteins, plasmids, peptides, oligonucleotides, and monoclonal antibodies. Enzymes are globular conjugated proteins that accelerate biological reactions by lowering the activation energy, thereby increasing the reaction rate. These biomolecules are utilized by various end users, including research, pharmaceuticals, and in vitro diagnostics (IVD).

Tariffs have impacted the non-therapeutic biomolecules market by increasing import costs of laboratory reagents, enzymes, and specialized biomolecule production equipment. This has affected research and pharma segments significantly, especially in Asia-Pacific and North America where imports are high. Industrial enzymes, recombinant proteins, and plasmids are among the most affected segments. Despite challenges, tariffs have encouraged local manufacturing and investment in domestic biomolecule production capabilities, potentially reducing future supply chain risks.

The non-therapeutic biomolecules market research report is one of a series of new reports from The Business Research Company that provides non-therapeutic biomolecules market statistics, including non-therapeutic biomolecules industry global market size, regional shares, competitors with a non-therapeutic biomolecules market share, detailed non-therapeutic biomolecules market segments, market trends and opportunities, and any further data you may need to thrive in the non-therapeutic biomolecules industry. This non-therapeutic biomolecules market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The non-therapeutic biomolecules market size has grown rapidly in recent years. It will grow from $33.92 billion in 2025 to $37.59 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to rising demand for research biomolecules, increasing adoption in in vitro diagnostics, growth in pharmaceutical research, advancements in recombinant protein technology, increasing collaborations between biotech firms.

The non-therapeutic biomolecules market size is expected to see rapid growth in the next few years. It will grow to $56.43 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to expansion in synthetic biomolecule applications, growing investment in precision medicine, increasing use in agricultural biotechnology, rising focus on sustainable and scalable biomolecule production, innovations in automated biomolecule synthesis platforms. Major trends in the forecast period include advanced protein engineering, high-throughput screening technologies, sustainable biomolecule production, cell-free biomolecule synthesis, customizable biomolecule platforms.

The rapidly growing number of research studies and laboratory tests is expected to drive the expansion of the non-therapeutic biomolecules market in the coming years. Laboratory testing involves analyzing samples of blood, urine, or other substances from the body to detect and monitor diseases and to develop treatment plans. Research, on the other hand, focuses on creating new knowledge or creatively applying existing knowledge to generate new concepts, theories, and understandings. In laboratory testing, non-therapeutic biomolecules are used to measure the presence or concentration of biomarker molecules, which indicate the presence of disease and enhance the sensitivity and specificity of tests. For example, in July 2024, the National Health Service (NHS), a UK-based healthcare provider, reported that diagnostic activity surpassed pre-pandemic levels in 2023, with a 21% increase in tests performed in May 2024 compared to the previous year. As a result, the increasing number of research and laboratory tests is fueling the growth of the non-therapeutic biomolecules market.

Leading companies in the non-therapeutic biomolecules market are focusing on developing new cell separation technologies to increase throughput and optimize processes, gaining a competitive edge. These innovative research-only kits are designed to address biological and laboratory workflow challenges. For instance, in May 2023, AcouSort AB, a Sweden-based biotechnology company, launched the AcouTrap 3 system. This system integrates the unique features of acoustofluidics, combining sound waves with microfluidics, to offer a streamlined solution for cell and extracellular vesicle isolation in a single workflow. The AcouTrap 3 system uses gentle acoustic trapping technology, enabling scientists to process more samples with higher cell viability and minimal loss compared to traditional column- or bead-based methods, thus improving productivity and optimizing laboratory operations.

In December 2023, Danaher Corporation, a U.S.-based life sciences and diagnostics conglomerate providing laboratory instruments, reagents, and consumables, acquired Abcam plc for an undisclosed amount. Through this acquisition, Danaher aims to expand its non-therapeutic biomolecule portfolio and strengthen its research-reagent business by integrating Abcam's antibodies, proteins, and immunoassay products into its global distribution and solutions platform. Abcam plc, a UK-based provider of research-use antibodies, proteins, immunoassays, and other reagent tools, is widely used in drug discovery, diagnostics, and academic research.

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Eppendorf AG, Bio-Techne Corporation, Vectalys, Avid Bioservices Inc.

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2025. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the non-therapeutic biomolecules market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-therapeutic biomolecule market consists of sales of monosaccharides, disaccharides, polysaccharides, heteropolysaccharides, structural proteins, hormones, respiratory pigments, storage proteins, toxins, deoxyribonucleic acids (DNA), ribonucleic acids (RNA), fatty acids, phospholipids, steroids, eicosanoids, and glycolipids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non-Therapeutic Biomolecules Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses non-therapeutic biomolecules market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for non-therapeutic biomolecules ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-therapeutic biomolecules market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Trad Pharma: Enzymes; Recombinant Proteins; Plasmids; Peptides; Oligonucleotides; Monoclonal Antibodies
• 2) By End User: Research; Pharma; In Vitro Diagnostics(IVD)
• 3) By Application: Diagnostic Equipment; Therapeutic Equipment; Monitoring Or Imaging Equipment; Laboratory Or Research Equipment; Rehabilitation Or Mobility Support
• Subsegments:
• 1) By Enzymes: Industrial Enzymes; Diagnostic Enzymes
• 2) By Recombinant Proteins: Antigens; Cytokines; Growth Factors
• 3) By Plasmids: Research Plasmids; Expression Plasmids
• 4) By Peptides: Antimicrobial Peptides; Signaling Peptides
• 5) By Oligonucleotides: Antisense Oligonucleotides; RNAi Oligonucleotides
• 6) By Monoclonal Antibodies: Research Antibodies; Diagnostic Antibodies
• Companies Mentioned: Amgen Inc.; Genentech Inc.; Merck KGaA; Lonza Group AG; Bio-Rad Laboratories Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Charles River Laboratories International Inc.; GE Healthcare Life Sciences; Fujifilm Diosynth Biotechnologies; Evonik Industries AG; Seikagaku Corporation; Takeda Pharmaceutical Company Limited; MilliporeSigma; Covance Inc.; Sartorius AG; Sanofi S.A.; CordenPharma International; Bayer AG; WuXi AppTec; Ginkgo Bioworks; Eppendorf AG; Bio-Techne Corporation; Vectalys; Avid Bioservices Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Non-Therapeutic Biomolecules Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Non-Therapeutic Biomolecules Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Non-Therapeutic Biomolecules Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Non-Therapeutic Biomolecules Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Advanced Protein Engineering
  • 4.2.2 High-Throughput Screening Technologies
  • 4.2.3 Sustainable Biomolecule Production
  • 4.2.4 Cell-Free Biomolecule Synthesis
  • 4.2.5 Customizable Biomolecule Platforms

5. Non-Therapeutic Biomolecules Market Analysis Of End Use Industries

• 5.1 Research Institutes
• 5.2 Pharmaceutical Companies
• 5.3 Biotechnology Companies
• 5.4 In Vitro Diagnostics (Ivd) Labs
• 5.5 Academic & Educational Institutions

6. Non-Therapeutic Biomolecules Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Non-Therapeutic Biomolecules Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Non-Therapeutic Biomolecules PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Non-Therapeutic Biomolecules Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Non-Therapeutic Biomolecules Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Non-Therapeutic Biomolecules Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Non-Therapeutic Biomolecules Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Non-Therapeutic Biomolecules Market Segmentation

• 9.1. Global Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies
• 9.2. Global Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Research, Pharma, In Vitro Diagnostics(IVD)
• 9.3. Global Non-Therapeutic Biomolecules Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostic Equipment, Therapeutic Equipment, Monitoring Or Imaging Equipment, Laboratory Or Research Equipment, Rehabilitation Or Mobility Support
• 9.4. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Industrial Enzymes, Diagnostic Enzymes
• 9.5. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antigens, Cytokines, Growth Factors
• 9.6. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Plasmids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Research Plasmids, Expression Plasmids
• 9.7. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Peptides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antimicrobial Peptides, Signaling Peptides
• 9.8. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Oligonucleotides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antisense Oligonucleotides, RNAi Oligonucleotides
• 9.9. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Research Antibodies, Diagnostic Antibodies

10. Non-Therapeutic Biomolecules Market Regional And Country Analysis

• 10.1. Global Non-Therapeutic Biomolecules Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Non-Therapeutic Biomolecules Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Non-Therapeutic Biomolecules Market

• 11.1. Asia-Pacific Non-Therapeutic Biomolecules Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Non-Therapeutic Biomolecules Market

• 12.1. China Non-Therapeutic Biomolecules Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Non-Therapeutic Biomolecules Market

• 13.1. India Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Non-Therapeutic Biomolecules Market

• 14.1. Japan Non-Therapeutic Biomolecules Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Non-Therapeutic Biomolecules Market

• 15.1. Australia Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Non-Therapeutic Biomolecules Market

• 16.1. Indonesia Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Non-Therapeutic Biomolecules Market

• 17.1. South Korea Non-Therapeutic Biomolecules Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Non-Therapeutic Biomolecules Market

• 18.1. Taiwan Non-Therapeutic Biomolecules Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Non-Therapeutic Biomolecules Market

• 19.1. South East Asia Non-Therapeutic Biomolecules Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Non-Therapeutic Biomolecules Market

• 20.1. Western Europe Non-Therapeutic Biomolecules Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Non-Therapeutic Biomolecules Market

• 21.1. UK Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Non-Therapeutic Biomolecules Market

• 22.1. Germany Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Non-Therapeutic Biomolecules Market

• 23.1. France Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Non-Therapeutic Biomolecules Market

• 24.1. Italy Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Non-Therapeutic Biomolecules Market

• 25.1. Spain Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Non-Therapeutic Biomolecules Market

• 26.1. Eastern Europe Non-Therapeutic Biomolecules Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Non-Therapeutic Biomolecules Market

• 27.1. Russia Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Non-Therapeutic Biomolecules Market

• 28.1. North America Non-Therapeutic Biomolecules Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Non-Therapeutic Biomolecules Market

• 29.1. USA Non-Therapeutic Biomolecules Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Non-Therapeutic Biomolecules Market

• 30.1. Canada Non-Therapeutic Biomolecules Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Non-Therapeutic Biomolecules Market

• 31.1. South America Non-Therapeutic Biomolecules Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Non-Therapeutic Biomolecules Market

• 32.1. Brazil Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Non-Therapeutic Biomolecules Market

• 33.1. Middle East Non-Therapeutic Biomolecules Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Non-Therapeutic Biomolecules Market

• 34.1. Africa Non-Therapeutic Biomolecules Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Segmentation By End User, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Non-Therapeutic Biomolecules Market Regulatory and Investment Landscape

36. Non-Therapeutic Biomolecules Market Competitive Landscape And Company Profiles

• 36.1. Non-Therapeutic Biomolecules Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Non-Therapeutic Biomolecules Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Non-Therapeutic Biomolecules Market Company Profiles
  • 36.3.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Non-Therapeutic Biomolecules Market Other Major And Innovative Companies

• Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec

38. Global Non-Therapeutic Biomolecules Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Non-Therapeutic Biomolecules Market

40. Non-Therapeutic Biomolecules Market High Potential Countries, Segments and Strategies

• 40.1 Non-Therapeutic Biomolecules Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Non-Therapeutic Biomolecules Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Non-Therapeutic Biomolecules Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer